NeuroScientific Biopharmaceuticals
is headquartered in Cottesloe, Western Australia. Nathan Smith is the CEO of NeuroScientific Biopharmaceuticals. NeuroScientific Biopharmaceuticals has acquired 1 companies, with the most recent being Isopogen WA for an undisclosed amount on Jun 2025. NeuroScientific Biopharmaceuticals has 1 followers on Owler.NeuroScientific Biopharmaceuticals
is headquartered in Cottesloe, Western Australia. Nathan Smith is the CEO of NeuroScientific Biopharmaceuticals. NeuroScientific Biopharmaceuticals has acquired 1 companies, with the most recent being Isopogen WA for an undisclosed amount on Jun 2025. NeuroScientific Biopharmaceuticals has 1 followers on Owler.
News
May 26, 2026
The Sydney Morning Herald
NeuroScientific Biopharmaceuticals: NeuroScientific hails 80% clinical response in Crohn's stem cell program
Mar 17, 2026
The Sydney Morning Herald
NeuroScientific Biopharmaceuticals: NeuroScientific readies stem cell supply boost for bowel disease trials
Jan 13, 2026
The Sydney Morning Herald
NeuroScientific Biopharmaceuticals: Neuroscientific Biopharmaceuticals soars on stem cell tech results
Jan 12, 2026
Finance News Network
NeuroScientific Biopharmaceuticals: NeuroScientific Biopharmaceuticals (ASX:NSB) Announces Successful Clinical Results for StemSmart in Crohn's Disease
Nov 11, 2025
The Sydney Morning Herald
NeuroScientific Biopharmaceuticals: NeuroScientific widens chronic bowel disease stem cell therapy program
Oct 07, 2025
The Sydney Morning Herald
NeuroScientific Biopharmaceuticals: TGA backs NeuroScientific stem cell assault on Crohn's disease
Aug 28, 2025
TipRanks
NeuroScientific Biopharmaceuticals: NeuroScientific Biopharmaceuticals Faces Financial Challenges Amidst Industry Struggles
Aug 28, 2025
TipRanks
NeuroScientific Biopharmaceuticals: Neuroscientific Biopharmaceuticals Ltd. Releases Corporate Governance Statement
Aug 27, 2025
TipRanks
NeuroScientific Biopharmaceuticals: NeuroScientific Biopharmaceuticals Reports Promising Results for StemSmart MSC in Renal Transplantation
Jul 31, 2025
Australian Manufacturing
NeuroScientific Biopharmaceuticals: NeuroScientific begins cell therapy manufacturing transfer to Q-Gen